期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

内源性肿瘤血管生成抑制物的研究进展 被引量：2

Research of angiongenesis inhibitors in endogenous tumor
在线阅读 下载PDF
导出
摘要 血管生成抑制物是目前肿瘤研究中的热点。其中内源性肿瘤血管生成抑制物是人体内源性蛋白的一部分 ,在控制肿瘤的生长和转移过程中发挥重要作用 ,其生理毒性小、不会产生耐药性 ,有着较好的抗癌前景。作者就内源性肿瘤血管生成抑制物的产生、结构、作用机制和临床应用等方面作一综述。 The treatment of tumor is now focusing on the angiogenesis inhibitors. Angiogenesis inhibitors of endogenous tumor are part of human endoprotein having low grade toxicity,without drug resistance. Angiongenesis inhibitors can prevent tumor progression. This review presents the origin,structure,mechanism,and clinical application with this new antitumor drugs.
作者 李黎 吴苏稼
机构地区 南京军区南京总医院 南京军区南京总医院
出处 《医学研究生学报》 CAS 2004年第6期542-545,共4页 Journal of Medical Postgraduates
关键词 血管生成抑制物 肿瘤 Angiongenesis inhibitors Tumor
分类号 R943 [医药卫生—药剂学]
  • 相关文献

参考文献25

  • 1[1]Dredge K, Dalgleish AG, Marriott JB. Angiogenesis inhibitors in cancer therapy[J]. Curr Opin Investig Drugs, 2003, 4(6):667-674.
  • 2[2]Folkman J. Role of angiogenesis in tumor growth and metastasis[J].Semin Oncol, 2002, 29(6 Suppl 16):15-18.
  • 3[3]Cavallaro U, Christofori G . Molecular mechanisms of tumor angiogenesis and tumor progression[J].Neurooncol, 2000,50(1-2):63-70.
  • 4[4]Dell′Eva R, Pfeffer U, Indraccolo S et al. Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy[J]. Endothelium, 2002,9(1):3-10.
  • 5[5]Folkman J. Role of angiogenesis in tumor growth and metastasis[J]. Semin Oncol, 2002, 29(6 Suppl 16):15-18.
  • 6[6]Sim BK, MacDonald NJ, Gubish ER. Angiostatin and endostatin: endogenous inhibitors of tumor growth[J].Cancer Metastasis Rev,2000, 19(1-2):181-190.
  • 7[7]Kunz M, Hartmann A. Angiogenesis--anti-angiogenesis. Significance for tumor growth and metastasis[J]. Hautarzt, 2002, 53(6):373-840.
  • 8[8]Kirsch M, Strasser J, Allende R et al. Angiostatin suppresses malignant glioma growth in vivo[J]. Cancer Res,1998, 58(20):4654-4659.
  • 9[9]Liu J,Razani B,Tang S et al.Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells.Angiogenesis inhibitors block vascular endotheliad growth factor-induced down-regulation of caveolin-1[J].J Biol chem,1999,274(22):15781-15785.
  • 10[10]Conti CJ. Vascular endothelial growth factor: regulation in the mouse skin carcinogenesis model and use in antiangiogenesis cancer therapy[J]. Oncologist, 2002, 7 (Suppl 3):4-11.

二级参考文献8

  • 1Chamber AF,Matrisian LM.Changing views of matrix metalloproteinase in metastasis[J].J Natl Cancer Inst,1997,89:1260-1265.
  • 2Weiderner N. Intratumor nicrovessel density as a prognostic factor in cancer [J].Am J Pathal,1995;147:9-19
  • 3Walkui S,Furusato M, Itoh T, et al. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study[J]. J Pathol, 1992,168:257-262.
  • 4Weiderner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow [J].J pathol,1998,184:119-122.
  • 5Person SL,Watson SA,Brown PD,et al. Matrix metalloproteinases[J]. Br J Surg,1997,84:160-166.
  • 6Person SL,Watson SA,Collins HM,et al.Gelatinase(MMP-2 and MMP-9) ecpressio in gastrointestinal malignancy[J].Br J Comcer,1998,78(11):1495-1502.
  • 7Lamper K,Machein U,Machein MR,et al. Expression of matrix metalloproteinasesand their tissue inhibitors in human brain tumors[J].Am Jpathol,1998,153:429-432.
  • 8Zeng ZS, CohenAM,GuillemJG. Loss of basement membrane type Ⅳ collagen is associated with increased expression of metalloprotemases 2 and 9(MMP-2 and MMP-9) during human colorectal tumorigenesis [J].Carcingenesis, 1999,20(5):749-745.

共引文献6

同被引文献24

  • 1Ranieri G, Gasparini G. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy[J]. Curr Drug Targets Immune Endocr Metabol Disord, 2001,1(3):241-253.
  • 2Dudek AZ, Pawlak WZ, Kirstein MN. Molecular targets in the inhibition of angiogenesis[J]. Expert Opin Ther Targets,2003,7(4):527-541.
  • 3kong HL, Crystal RG. Gene therapy strategies for tumor antiangiogenesis[J]. J Natl Cancer Inst, 1998,90(4):273-286.
  • 4Nesbit M. Abrogation of tumor vasculature using gene therapy[J]. Cancer Metastasis Rev, 2000,19(1-2):45-49.
  • 5Webb CP, Vande Woude GF. Genes that regulate metastasis and angiogenesis[J]. J Neurooncol, 2000,50(1-2):71-87.
  • 6Cavallaro U, Christofori G. Molecular mechanisms of tumor angiogenesis and tumor progression[J]. J Neurooncol, 2000, 50(1-2):63-70.
  • 7Conti CJ. Vascular endothelial growth factor: regulation in the mouse skin carcinogenesis model and use in antiangiogenesis cancer therapy[J]. Oncologist, 2002,7(Suppl 3):4-11.
  • 8Bandoh N, Hayashi T, Takahara M et al. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis[J]. Cancer Lett, 2004, 208(2): 215-225.
  • 9Kieran MW, Billett A. Antiangiogenesis therapy: current and future agents[J]. Hematol Oncol Clin North Am, 2001,15(5):835-851.
  • 10Harlozinska A, Sedlaczek P, Kulpa J et al. Vascular endothelial growth factor(VEGF) concentration in sera and tumor effusion from patients with ovarian carcinoma[J]. Anticancer Res, 2004, 24(2C):1149-1157.

引证文献2

二级引证文献19

医学研究生学报
2004年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部